Announcements Trials
Browse Landscape

Phase

Phase NA 4Phase 3 1Phase 2 1

Status

Completed 26Recruiting 15Active not recruiting 8Unknown 6Terminated 5Not yet recruiting 2Withdrawn 1Suspended 1

Sponsor Class

OTHER 4OTHER_GOV 2

Study Type

Interventional 6

Sponsor

Cancer Type

Genitourinary 2Other hematologic neoplasm 1Head & Neck 1CNS 1

Conditions

Prostatic Neoplasms 2Thyroid Neoplasms 1Musculoskeletal Diseases 1Leukemia, Myeloid, Acute 1Glioma 1Disease 1Brain Neoplasms 1

Interventions

Cisplatin 509Cyclophosphamide 360Carboplatin 352Radiotherapy 350Capecitabine 329Paclitaxel 325Oxaliplatin 324Gemcitabine 319Docetaxel 311Fluorouracil 283Drug Therapy 243apatinib 242Bevacizumab 229camrelizumab 214Etoposide 200Irinotecan 176Doxorubicin 175Leucovorin 161Dexamethasone 160sintilimab 142pembrolizumab 138anlotinib 136Pemetrexed 136Cytarabine 136toripalimab 129Neoadjuvant Therapy 122S 1 (combination) 120Vincristine 119Rituximab 117Radiosurgery 117

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Unknown × Interventional × Congresses as Topic × Clear all
NCT04737577 2023-06-18

G-SUMIT

Sunnybrook Health Sciences Centre

Phase NA Unknown
72 enrolled
CNS

Brain Neoplasms, Glioma

NCT03454464 2018-09-18

Evaluation of Central Compartment Dissection Without Thyroidectomy

Fujian Medical University

Phase NA Unknown
100 enrolled
Head & Neck

Thyroid Neoplasms

NCT03453905 2018-03-05

ZYCTFEA

Tel-Aviv Sourasky Medical Center

Phase NA Unknown
162 enrolled

Disease, Musculoskeletal Diseases

NCT02934685 2016-11-18

IG-VMAT for Localized Prostate Cancer

Beijing Hospital

Phase 3 Unknown
60 enrolled
Genitourinary

Prostatic Neoplasms

NCT02484339 2016-04-27

α-RT

University Hospital Freiburg

Phase 2 Unknown
274 enrolled
Genitourinary

Prostatic Neoplasms

NCT01188330 2013-10-31

MLSP

Institut Paoli-Calmettes

Phase NA Unknown
100 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡